Examining Uncomplicated UTI Recurrence

Author(s):

Ryan Haumschild, PharmD, MS, MBA,Thomas M. Hooton, MD

Panelists discuss how uncomplicated urinary tract infection (UTI) recurrence affects 20% to 30% of female patients within 6 months of initial infection, with contributing factors including anatomical variances, hormonal changes, genetic predisposition, insufficient treatment duration, resistant pathogens, and biofilm formation that persists despite proper adherence to standard antibiotic protocols.

EP: 1.Differentiating Uncomplicated and Complicated Urinary Tract Infections (UTIs)

EP: 2.Trends in Uncomplicated UTIs

EP: 3.Exploring Social Determinants of Health in Uncomplicated UTIs

Now Viewing

EP: 4.Examining Uncomplicated UTI Recurrence

EP: 5.Role of Patients’ Education in Uncomplicated UTIs

EP: 6.Patient Burden Associated With Uncomplicated UTIs

EP: 7.Minimizing Antibiotic Resistance Development in Uncomplicated UTIs

EP: 8.Examining the Need for Updated Guidelines for Uncomplicated UTIs

EP: 9.Comparing Standard-of-Care Antibiotics for Uncomplicated UTIs

EP: 10.Patient Factors Influencing Antibiotic Selection in Uncomplicated UTIs

EP: 11.Recurrence Rates in Uncomplicated UTIs

EP: 12.Economic Burden Associated With Uncomplicated UTIs

EP: 13.Important Updates in the Management of Uncomplicated UTIs

EP: 14.Exploring Novel Options for the Management of Uncomplicated UTIs

EP: 15.Comparing Newer With Traditional Agents in Uncomplicated UTIs

EP: 16.Payer-Related Barriers With Therapies Used for Uncomplicated UTIs

EP: 17.Final Panel Thoughts on Uncomplicated UTI Management

Video content above is prompted by the following:

How common is recurrence of uncomplicated UTIs across various patient populations, and what factors contribute most to recurrences despite adherence to standard treatments?

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!